Suppr超能文献

[一例内分泌治疗抵抗的前列腺癌经动脉内化疗成功治疗的病例报告]

[A case report of prostate cancer resistant to endocrine therapy successfully treated with intra-arterial chemotherapy].

作者信息

Mima H, Asano M, Ozeki S, Ehara H, Takahashi Y, Ishihara S, Deguchi T, Kuriyama M, Ban Y, Kawada Y

机构信息

Dept. of Urology, Gifu University School of Medicine.

出版信息

Gan To Kagaku Ryoho. 1995 Sep;22(11):1694-6.

PMID:7574795
Abstract

A 73-year-old male with low abdominal pain on urination and frequent urination was diagnosed as poorly differentiated adenocarcinoma of prostate. He received endocrine therapy with DESD and bilateral orchiectomy. This treatment was not effective, so he was given intra-arterial infusion chemotherapy with MTX, ADM and CDDP using the reservoir system. After 2 courses of this chemotherapy the regression rate was 75%, and the pathological examination after the chemotherapy revealed no cancer cells. There is no established chemotherapy for prostate cancer at present. Thus this case is very suggestive for the treatment of prostate cancer.

摘要

一名73岁男性,排尿时伴有下腹部疼痛及尿频,被诊断为前列腺低分化腺癌。他接受了己烯雌酚(DESD)内分泌治疗及双侧睾丸切除术。该治疗无效,因此使用储液器系统给予甲氨蝶呤(MTX)、多柔比星(ADM)和顺铂(CDDP)进行动脉内灌注化疗。经过2个疗程的这种化疗后,缓解率为75%,化疗后的病理检查未发现癌细胞。目前尚无公认的前列腺癌化疗方案。因此,该病例对前列腺癌的治疗具有很大的启示意义。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验